Article
Site-Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer.
Cancer reports (Hoboken, N.J.) - 1 Jul 2025
Yoshimura Fumihiro, Yoshida Yoichiro, Yamada Teppei, Tanaka Keita, Hayashi Takaomi, Shimaoka Hideki, Sakamoto Ryohei, Aisu Naoya, Yoshimatsu Gumpei, Hasegawa Suguru
Abstract excerpt
BACKGROUND: Early prediction of metastatic risk after tumor resection for colorectal cancer (CRC) is critical to improve treatment outcomes. Although circulating tumor DNA (ctDNA) is an important biomarker in CRC patients, positivity is variable because cutoff values for each gene have not been clearly established. When examining the mutant allele frequency (MAF) of a gene, the cutoff value is the same for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
